Moderna, Visa, and Coca-Cola Hit 52-Week Highs on Corporate Milestones
Moderna, Inc. (MRNA), The Coca-Cola Company (KO), and Visa Inc. (V) reached fresh 52-week highs on Thursday following a series of encouraging business developments. Shares of Moderna advanced over 4% to touch a multi-year peak of $242.29 before settling at $236.50. Meanwhile, Visa surged over 2% to $399.80 after setting an all-time high of $403.21, and Coca-Cola closed at $92.00 after touching a record high of $94.10.
The gains reflect positive company-specific catalysts boosting investor confidence. Goldman Sachs raised its price target on Moderna to $137 from $120, citing momentum in its oncology pipeline. Visa benefited from a price target boost to $425 from $405 at BMO Capital Markets, driven by steady payment activity and growth in fraud prevention and analytics services. Meanwhile, Coca-Cola gained momentum after KFC announced its U.S. restaurants will switch from PepsiCo products to Coca-Cola beverages, providing access to thousands of restaurant outlets.
Investors will track incoming healthcare data and corporate expansion efforts. Moderna is set to present Phase 3 melanoma data for its experimental cancer therapy, intismeran, at the European Society for Medical Oncology Congress on October 24. Markets will also monitor Visa's ongoing expansion into cross-border business payments and tokenization technology, alongside Coca-Cola's rollout across KFC locations.
Key points
- Moderna Inc. (MRNA) climbed over 4% after Goldman Sachs raised its price target to $137 from $120.
- Visa Inc. (V) touched an all-time high of $403.21 following a BMO Capital price target increase to $425.
- The Coca-Cola Company (KO) hit a record high of $94.10 as KFC selected its beverages for U.S. restaurants.
- Moderna will present Phase 3 melanoma data for experimental therapy intismeran on October 24.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
Why did Moderna stock reach a 52-week high?
Moderna Inc. stock rose over 4% after Goldman Sachs increased its price target to $137 from $120. Investor interest also grew ahead of Phase 3 melanoma vaccine results scheduled for presentation at the ESMO Congress on October 24.
Why did Coca-Cola stock hit a record high?
The Coca-Cola Company stock reached a record high of $94.10 after news that KFC will switch its U.S. restaurant beverage partner from PepsiCo to Coca-Cola, expanding Coca-Cola's presence in thousands of dining locations.
Why did Visa stock hit an all-time high?
Visa Inc. stock reached a record high of $403.21 after BMO Capital raised its price target to $425 from $405, citing stable consumer payment volume and rapid expansion in fraud prevention, cybersecurity, and analytics services.